Microdosing GLP-1: Benefits, Risks, and What the Research Really Says Thinking about microdosing GLP-1
1 2 "GIP and GLP-1, the two incretin hormones: Similarities and differences"
The FDA continues to explain GLP-1 drugs should not be used in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Today, experts agree that there is no real risk of thyroid cancer associated with GLP-1 drugs
We used the Frisn staging scale to rate papilledema severity, categorizing the swelling of optic discs from stage 0 (no papilledema) to stage 5 (severe papilledema) [19]
In the future, to improve spectral resolution and reduce scanning time, we and our collaborators have been preparing to develop a 1 H- 2 H surface coil, which theoretically has higher sensitivity and resolution compared with the birdcage volumetric coil in this work